Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,240 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details
Recruiting

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

NCT06162221

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • City of Hope - Lennar Irvine, California, United States
  • UC Davis, Davis Comprehensive Cancer Center Sacramento, California, United States
View all 93 locations
View Trial Details
Recruiting

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

NCT07327489

Conditions
Advanced Solid Tumors Cancer, Bladder Cancer, Breast Diseases, +64 more
Locations
  • Mercy Hospital - FTS Fort Smith, Arkansas, United States
  • Frederick Health Hospital Frederick, Maryland, United States
  • Mercy Hospital - SPG Springfield, Missouri, United States
  • Mercy Hospital - South St Louis, Missouri, United States
View Trial Details
Recruiting

GCC 2546- Motion Management

NCT07398209

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

NCT06914128

Conditions
Astrocytoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +17 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • UCLA Health Bowyer Oncology Center Los Angeles, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights - Neurology San Francisco, California, United States
View all 60 locations
View Trial Details
Recruiting

Gilteritinib for the Treatment of ALK NSCLC

NCT06225427

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

NCT07140016

Conditions
Anaplastic Lymphoma Kinase (ALK) Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center Fullerton, California, United States
  • University of California - Irvine Orange, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • OSF Health Care Peoria, Illinois, United States
View all 16 locations
View Trial Details

Related conditions